Expansionary Institute

Major October Meeting on Stem Cell Role in Drug Discovery, (Biogenesis)

Major October Meeting on Stem Cell Role in Drug Discovery

Potential Role of Stem Cells in the Discovery of New Drugs to be Addressed at October 14-15 Meeting

NEW YORK, Aug. 20 /PRNewswire/ -- The prospective role of human neural stem cells in the screening of potential pharmaceutical compounds will be presented as part of an industrial stem cell and regenerative therapeutic research meeting to be held this October in Princeton, NJ, announces Strategic Research Institute.

Following two highly successful events, the third annual meeting features researchers from the stem cell industry's leading biotech and biopharmaceutical companies as well as pioneering scientists from academia as they present their most recent data.

Topics to be covered Human Embryonic Stem Cells, Cord Blood Derived and Bone Marrow Stem Cells, CNS Stem Cell Transdifferentiation and Transplantation, Implications for Drug Discovery, Bioethics of Stem Cell Research, and Commercial and Federal Regulatory Implications for the Pharmaceutical and Biotech Industries.

Over 25 companies including Geron Corporation, Stem Cell Sciences, Bresagen, NeuralStem, Neuronyx, NeuroNova, Osiris Therapeutics, Genzyme Corporation, Thrombogenics, and many others will discuss their role in stem cell research to an broad audience comprised of pharmaceutical, academic and biotech researchers and executives.

To register, request announcement, and/or for sponsorship/exhibition information, please contact Steve J. Kuperberg at skuperberg@srinstitute.com

(Please include company/university and mailing address)

Registration is available online at www.srinstitute.com/cs254/register.htm

SOURCE Strategic Research Institute

CO: Strategic Research Institute

ST: New York

SU: TDS

Web site: www.srinstitute.com

www.prnewswire.com

08/20/2003 08:51 EDT

Tue Aug 26